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Objectives: To assess the link between perfusion, metabolism, and function in viable myocardium before
and early after surgical revascularisation.
Design: Myocardial blood flow (MBF, thermodilution technique), metabolism (lactate, glucose, and free
fatty acid extraction and fluxes), and function (transoesophageal echocardiography) were assessed in
patients with critical stenosis of the left anterior descending coronary artery (LAD) before and 30 minutes
after surgical revascularisation.
Setting: Tertiary cardiac centre.
Patients: 23 patients (mean (SEM) age 57 (1.7) years with LAD stenosis: 17 had dysfunctional viable
myocardium in the LAD territory, as shown by thallium-201 rest redistribution and dobutamine stress
echocardiography (group 1), and six had normally contracting myocardium (group 2).
Results: LAD MBF was lower in group 1 than in group 2 (58 (7) v 113 (21) ml/min, p , 0.001) before
revascularisation and improved postoperatively in group 1 (129 (133) ml/min, p , 0.001) but not in
group 2 (105 (20) ml/min, p = 0.26). Group 1 also had functional improvement in the LAD territory at
intraoperative echocardiography (mean regional wall motion score from 2.6 (0.85) to 1.5 (0.98),
p , 0.01). Oxidative metabolism, with lactate and free fatty acid extraction, was found preoperatively
and postoperatively in both groups; however, lactate and free fatty acid uptake increased after
revascularisation only in group 1.
Conclusions: MBF is reduced and oxidative metabolism is preserved at rest in dysfunctional but viable
myocardium. Surgical revascularisation yields immediate perfusion and functional improvement, and
increases the uptake of lactate and free fatty acids.
M
yocardial hibernation refers to chronic cardiac dys-
function subtending critical coronary artery stenosis,
which can be partially or completely restored by
coronary revascularisation.1 Although metabolic adaptation
in the myocardial areas supplied by critical stenotic lesions
has been recognised,2 3 other reports have questioned this
hypothesis on the grounds of the possibility of cell
dedifferentiation,4 cell degeneration, or both.5 The mechan-
ism of chronic post-ischaemic reversible dysfunction is likely
to be multifactorial and to entail ultrastructural and
metabolic changes; the different contributions of each of
these mechanisms may explain the variable extent and delay
of functional recovery after successful revascularisation.
However, a few clinical studies6 7 have addressed the
hypothesis that the reversibility of chronic dysfunction after
blood flow restoration provides evidence of a pathophysiolo-
gical link between flow and function.
In the clinical setting, it is not known whether metabolic
adaptation to chronic hypoperfusion is sustained by anaero-
bic metabolism that reverts after flow restoration or whether
the physiological aerobic pathways are downregulated.
The aim of this study was to define preoperatively the
behaviour of regional perfusion, metabolism, and function in
viable myocardial regions with chronic asynergy and to assess
the effects of coronary revascularisation on these parameters.
To this purpose, we selected candidates for coronary artery
bypass graft (CABG) surgery with stable angina pectoris,
critical coronary lesion in the left anterior descending
coronary artery (LAD), and LAD dependent dysfunctional
viable myocardium.
METHODS
Study population
One hundred and seven consecutive patients with stable
angina pectoris and regional left ventricular dysfunction who
underwent elective CABG surgery were screened for myo-
cardial viability in the LAD territory according to the
American College of Cardiology/American Heart Association
guidelines. Twenty three patients (mean (SEM) age 57 (1.7)
years) fulfilled the following inclusion criteria: (1) no history
of previous myocardial infarction; (2) no unstable angina
before surgery; (3) onset of clinical symptoms lasting no
longer than one year; (4) evidence of critical (> 70%) LAD
stenosis and the possibility of achieving complete surgical
revascularisation of all diseased vessels; and (5) no sig-
nificant concomitant valvar disease, severe pulmonary dis-
ease, diabetes, or arterial hypertension. Seventeen patients
had dysfunctional viable myocardium only in the LAD
dependent territory as assessed by dobutamine stress
echocardiography and rest redistribution thallium-201 single
photon emission computed tomography (201Tl-SPECT)
(group 1). The other six patients had normal left ventricular
function (group 2). No patient among those with dysfunc-
tional myocardium had a left ventricular aneurysm. Ten
patients had single LAD disease, 10 patients had double
Abbreviations: CABG, coronary artery bypass graft; LAD, left anterior
descending coronary artery; MBF, myocardial blood flow; RPP, rate–
pressure product; 201Tl-SPECT, thallium-201 single photon emission
computed tomography
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vessel disease, and three patients had triple vessel disease.
Table 1 shows the preoperative clinical and angiographic
features and the operative findings in the two groups.
Study protocol
The baseline studies before revascularisation were two
dimensional transthoracic echocardiography at rest for both
groups, and dobutamine stress echocardiography and rest
four hour redistribution 201Tl-SPECT for group 1 only.
Dobutamine stress echocardiography was performed 3 (1.1)
days before surgery and within one day of 201Tl-SPECT.
Significant coronary artery disease was defined as the
percentage reduction of the internal lumen diameter
> 70%. Left ventricular function was evaluated in all of the
patients by means of monoplane contrast ventriculography
(30˚ right oblique anterior view); left ventricular ejection
fraction was calculated by the area–length method.
All of the patients were then studied during CABG surgery
after opening of the pericardium, systemic heparinisation,
and cannulation of the ascending aorta. Intraoperative
studies were transoesophageal echocardiography, myocardial
blood flow (MBF) measurement, and arterial and great
cardiac vein blood sampling.
After the coronary bypass procedure was completed and
about 30 minutes after the patient was weaned from
cardiopulmonary bypass, transoesophageal echocardiogra-
phy, MBF, and arterial and great cardiac vein blood sampling
were repeated under the haemodynamic conditions closest to
the preoperative ones (fig 1).
All of the patients underwent transthoracic echocardio-
graphy at rest one week and three months after surgery.
The study protocol was approved by the ethics committee
of the Centro Cardiologico Monzino. Written informed
consent was obtained from all patients.
Echocardiographic studies
All patients underwent transthoracic echocardiography
with a commercial ultrasonograph (Hewlett Packard Sonos
1500) and 2.5–3.5 MHz transducers. Standard parasternal
short axis, apical four chamber, and apical two chamber
views were acquired and recorded on VHS tape, and the
baseline left ventricular ejection fraction was calculated.8
Subsequently, group 1 patients underwent dobutamine
infusion and echocardiographic monitoring according to
previously described methods.9 Data were analysed off line
by two independent observers unaware of the clinical,
scintigraphic, and angiographic findings; discrepancies were
resolved by consensus.
Regional wall motion scores were assessed according to the
16 segment model from review of the videotapes in a quad
screen format. The number of resting asynergic segments to
the LAD territory, their resting motion score, and their
maximum score improvement during dobutamine infusion
were recorded. The average baseline and maximum improve-
ment scores were computed. Contractile reserve was con-
sidered to be present either when the systolic wall thickening
score improved in at least two adjacent abnormal segments or
when subsequent doses were associated with an ischaemia
induced worsening (biphasic response). Intraobserver and
interobserver variabilities in describing improved or
unchanged segments during dobutamine infusion in our
laboratory are 4.5% and 9.2%, respectively.
Table 1 Clinical variables in the study population
Variable Group 1 (n = 17) Group 2 (n = 6) p Value
Age (years) 58 (2) 55 (4) 0.487
BSA (m2) 1.88 (0.05) 1.85 (0.22) 0.678
Male sex 17 5 0.543
Previous MI 0 0 1
Stable angina 17 6 1
Angiographic EF (%) 51.4 (6.1) 63.2 (5.5) ,0.001
LAD lumen reduction (%) 92.4 (9.5) 89.8 (10.9) 0.585
RCA stenosis 7 2
Circumflex artery stenosis 5 2
Distal anastomoses 2.5 (0.2) 1.9 (0.3) 0.081
LIMA use 17 6 1
CPB time (min) 73 (7) 59 (8) 0.311
Aortic cross clamp time (min) 52 (5) 38 (2) 0.150
Data are mean (SEM).
BSA, body surface area; CPB, cardiopulmonary bypass; EF, ejection fraction; LAD, left anterior descending
coronary artery; LIMA, left internal mammary artery; MI, myocardial infarction; RCA, right coronary artery.
Figure 1 Study protocol. A-GCV,
arterial and great cardiac vein blood
sampling; MBF1–4, first through fourth
myocardial blood flow determinations;
postop, postoperative; preop,
preoperative; TOE, transoesophageal
echocardiography; Xclamp, cross
clamping.
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Intraoperative transoesophageal echocardiography was
performed with a multiplane transoesophageal instrument
(omniplane model 21364A, Hewlett Packard) with a 5 MHz
phased array transducer. The short axis, four chamber, and
two chamber views were recorded with the transducer
positioned in the mid oesophagus. Segmental wall motion
was analysed by dividing the ventricle into the same 16
segments as those used for dobutamine stress echocardio-
graphy. A longitudinal image of the left ventricle orthogonal
to the short axis, including the apex, and of the inferior and
anterosuperior walls of the ventricle, allowed adequate
visualisation of the endocardial surfaces.
Rest redistribution 201Tl-SPECT
Group 1 patients underwent rest (2.8 mCi, 103.6 MBq) four
hour redistribution 201Tl-SPECT protocol within one day of
dobutamine stress echocardiography. The tomograms
(646 64 matrix) were acquired early and four hours after
tracer injection with a rotating gamma camera (Starcam
3000, General Electric) and a low energy general purpose
collimator in a 180˚circular orbit (from the 45˚right anterior
oblique projection to the 45˚left posterior oblique projection)
with 32 steps for 40 second acquisition. The left ventricular
short axis slices were reconstructed every 6 mm. From three
representative apical, mid ventricular, and basal short axis
sections, 16 segments matching the transoesophageal echo-
cardiographic and transthoracic echocardiographic segments
were automatically drawn by computer and analysed
quantitatively.
The quantitative assessment was made by normalising the
201Tl uptake in each segment to the segment with the highest
uptake: 201Tl activity was considered normal when it was 75–
100%, moderately reduced at 50–74%, and severely reduced
at 0–49%. A segment was considered viable when the 201Tl
activity was > 50% of the maximum activity recorded in the
resting or redistribution images.
Surgical procedure
The management of the patients during and after the
operation has been described elsewhere.10
Blood pressures were monitored with the use of a radial
artery and a flow directed pulmonary artery catheter. The
patients were cooled to 29–31 C˚. For purposes of myocardial
protection, the patients received multidose antegrade and
retrograde high potassium cold crystalloid cardioplegia.
Distal graft anastomoses were positioned during aortic cross
clamping: the LAD and its branches were always revascu-
larised with the left in situ internal mammary artery, with
sequential anastomoses as needed. When necessary, addi-
tional coronary vessels were revascularised with the great
saphenous vein. Complete revascularisation was achieved in
every patient.
Haemodynamic measurements
Heart rate, systolic, diastolic, and mean aortic pressures, right
atrial pressure, pulmonary capillary wedge pressure, and
cardiac output (by the thermodilution technique) were
measured. The derived haemodynamic measurements were
systemic vascular resistance and rate–pressure product
(RPP).
All of the measurements were recorded in duplicate in the
operating room during flow and echocardiographic measure-
ments.
Coronary blood flow measurement
Soon after cannulation of the ascending aorta, a thermodilu-
tion catheter (CCS 7W 9A Ball End, Webster Laboratories)
connected to a flowmeter (CF-300A, Webster Laboratories)
was surgically advanced into the coronary sinus and inserted
into the great cardiac vein under direct vision. Advancement
of the thermodilution catheter tip to where the anterior
intraventricular vein meets the great cardiac vein provides
the most stable position and the most selective measurement
of LAD territory outflow. The constant position of the
catheter tip, critical to assure the reliability of measurement,
was checked by direct vision, with the position of the tip
marked by a metal clip applied to the fat behind the left atrial
appendage. Measurements at this position indicate primarily
LAD venous outflow.
Under stable haemodynamic conditions, MBF was mea-
sured with a syringe infuser to inject room temperature
normal saline at a constant rate (50 ml/min) through the
thermodilution catheter. The deflection from baseline was
recorded with a jet polygraph (Mingograf 34, Siemens
Elema) and millimetre paper, and compared with a standard
deflection. The great cardiac vein flow measurements were
considered stable when there was a , 10% variation in the
resting value obtained from three repeated measurements.
The measurements were made in duplicate using the
continuous infusion thermodilution method.11 Because basal
MBF is closely related to the RPP, MBF data before and after
revascularisation in both patient groups are reported after
correction for RPP by the equation RPP corrected
MBF = basal MBF6 (mean patient RPP/individual RPP),
as previously described.12
Arterial and great cardiac vein blood sampling
Before and after the MBF determinations, blood was
simultaneously collected from the radial artery and great
cardiac vein catheter in two syringes (one heparinised and
one containing fluoride-EDTA as anticoagulant) and imme-
diately capped and put in ice. The contents of the heparinised
syringe were used for blood gas analyses. Myocardial oxygen
consumption was calculated as the product of great cardiac
vein flow and the artero-great cardiac vein blood oxygen
concentration difference and corrected for RPP.12 The second
syringe was immediately centrifuged in a refrigerated
centrifuge to separate the plasma and metabolically deter-
mine the plasma concentrations of lactate, glucose, and free
fatty acids by means of modified versions of previously
described methods.13 14 Lactate, glucose, and free fatty acid
concentrations in each plasma sample (two before and two
after CABG surgery) were measured in duplicate and the
mean values were used for analysis.
Postoperative echocardiography and follow up
One week and three months after revascularisation, all of the
patients underwent a transthoracic echocardiography exam-
ination. Results were reviewed by two independent observers
to assess segmental wall motion.
Statistical analysis
The data are presented as mean (SEM). Student’s t test for
paired and unpaired samples or one way analysis of variance
(followed by Bonferroni correction when indicated) was used
for within group or between groups comparisons of con-
tinuous variables. Fisher’s exact test was used to compare
categorical variables. The analysis of Bland and Altman15 was
used to assess the agreement between repeated measure-
ments of MBF before and after revascularisation. A prob-
ability value of p , 0.05 was considered significant. SPSS
version 6.0 for Windows (SPSS Inc, Chicago, Illinois, USA)
was used for all analyses.
RESULTS
Clinical features
The patients in group 1 were found to have 78 asynergic LAD
related segments (4.6 per patient) at both preoperative
Flow, metabolism, and function in viable myocardium 1293
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transthoracic echocardiography and intraoperative pre-
procedure transoesophageal echocardiography. Hypokinesis,
akinesis, or dyskinesis was found in 24, 47, and 7 segments,
respectively. Seventy one of these segments (91%) were
viable on 201Tl-SPECT and 61 (78%) on dobutamine stress
echocardiography. Only 10 segments (five patients) viable on
201Tl-SPECT were judged to be non-viable by stress echo-
cardiography criteria. All of these segments were akinetic at
baseline evaluation. Seven of 10 segments had improved at
three months’ follow up. Only seven segments (9%) were
judged to be necrotic by both 201Tl-SPECT and stress
echocardiography.
All of the CABG operations were successful and uncom-
plicated and no patient needed inotropic drugs.
Haemodynamic measurements
Table 2 shows the haemodynamic profiles of the patients in
groups 1 and 2 before and after CABG surgery. In group 1,
pulmonary capillary wedge pressure did not change; heart
rate, cardiac output, and RPP increased significantly; and
peripheral vascular resistance decreased. In group 2, there
was no change in right atrial and pulmonary capillary wedge
pressure, cardiac output, or RPP; heart rate increased
significantly; and both systolic and diastolic arterial blood
pressures decreased significantly. The reduction in peripheral
vascular resistance, albeit non-significant, in group 2 was
similar to that observed in group 1.
Myocardial blood flow
LAD blood flow was significantly lower in group 1 than in
group 2 before revascularisation. After surgery, RPP corrected
MBF increased significantly in group 1, whereas no
significant changes were detected in group 2. Moreover,
there were no significant differences between repeated
measurements in both groups and in postoperative flow
measurements between groups (table 3, fig 2), as documen-
ted by Bland-Altman analysis of agreement, which showed a
mean MBF change between duplicate measurements of
1.5 ml/min and 1.7 ml/min before and after revascularisa-
tion, respectively. Limits of agreement ranged from 212.5 to
15.6 ml/min in pre-revascularisation measurements and from
214.2 to 19.3 ml/min in post-revascularisation measure-
ments (mean (2SD)).
The postoperative increase in group 1 MBF was associated
with a significant increase in myocardial oxygen consump-
tion. In group 2 there were no significant changes (table 3).
Lastly, no significant changes in myocardial oxygen extrac-
tion were detected perioperatively in both groups or between
groups (table 3).
Metabolic determinations
In both groups, there was no significant difference between
the prerevascularisation and post-revascularisation lactate
(fig 3), glucose (fig 4), and free fatty acid extraction rates
(fig 5); lactate (fig 3A) and free fatty acid fluxes (fig 5A)
increased significantly in group 1 after surgery. No significant
differences were detected in preoperative and postoperative
extraction rates and fluxes between group 1 and 2, with the
exception of preoperative free fatty acid fluxes, which were
significantly higher in group 2 patients (p = 0.039).
Left ventricular function
No significant differences were observed between wall
motion scores taken during baseline transthoracic echocar-
diography at rest and those during prerevascularisation
transoesophageal echocardiography. Regional wall motion
improved significantly at dobutamine stress echocardiogra-
phy with respect to baseline transthoracic echocardiography
and preoperative transoesophageal echocardiography. The
post-revascularisation regional wall motion score at trans-
oesophageal echocardiography improved significantly with
respect to pre-revascularisation measurements and it was of
the same magnitude as that observed at transthoracic
echocardiography eight days and three months after surgery
(table 4). Among the 78 asynergic segments, 89%, 83%, and
43% of the hypokinetic, akinetic, and dyskinetic segments,
respectively, improved or normalised function. Figure 6
shows the individual behaviour of perioperative great cardiac
vein blood flow and regional wall motion score changes in
group 1 patients.
No perioperative functional changes in the LAD wall
segments were observed in group 2; furthermore, the
segments unrelated to the LAD territory displayed neither a
hyperkinetic pattern nor the occurrence of new regional wall
motion abnormalities after revascularisation.
DISCUSSION
This is the first report of a simultaneous assessment of
regional MBF, metabolism, and function in patients with
stable angina pectoris and dysfunctional viable myocardium
before and soon after surgical coronary revascularisation.
The main findings of this study are that, firstly, viable
myocardial regions with chronic asynergy have a reduced
baseline MBF, which increases soon after revascularisation;
secondly, improvement of perfusion is paralleled by an early
recovery of contractile function in most of the asynergic
territories; and thirdly, oxidative metabolism is present in
these regions and increases substantially after blood flow is
restored.
Table 2 Haemodynamic data before and after coronary artery bypass graft surgery
Group 1 patients (n = 17) Group 2 patients (n = 6) p Value group 1 v group 2
Preop Postop p Value Preop Postop p Value Preop Postop
Heart rate (beats/min) 68 (2.7) 81 (2.4) 0.001 75 (3.7) 93 (5.5) 0.044 0.182 0.030
SBP (mm Hg) 115 (3.0) 117 (2.8) 0.607 128 (8.3) 117 (8.1) 0.001 0.076 1
DBP (mm Hg) 66 (2.4) 64 (1.7) 0.411 77 (3.3) 67 (3.8) 0.023 0.024 0.416
MBP (mm Hg) 84 (2.3) 80 (1.7) 0.057 97 (4.3) 85 (5.6) 0.005 0.010 0.259
RPP (beats/min6mm Hg) 7812 (396) 9593 (424) 0.001 9677 (1117) 10839 (900) 0.19 0.06 0.17
Cardiac output (l/min) 4.0 (0.32) 5.1 (0.35) 0.005 4.8 (1.13) 4.8 (0.94) 0.928 0.353 0.712
PCWP (mm Hg) 9 (1.0) 10 (0.8) 0.097 9 (0.6) 9 (0.8) 1.000 1.000 0.495
Right atrial pressure (mm Hg) 6 (0.6) 7 (0.6) 0.004 5 (1.3) 6 (1.0) 0.374 0.437 0.403
PVR (dynes6cm/s25) 1672 (136) 1239 (66) 0.005 1734 (327) 1214 (113) 0.230 0.837 0.849
Data are mean (SEM).
DBP, diastolic blood pressure; MBP, mean blood pressure; PCWP, pulmonary capillary wedge pressure; Postop, postoperative data; Preop, preoperative data;
PVR, peripheral vascular resistance; RPP, rate–pressure product; SBP, systolic blood pressure.
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Blood flow reduction in viable asynergic regions
Findings of MBF in viable segments with chronically
impaired contractile function conflict in the literature.
Reversible left ventricular dysfunction has been alternatively
regarded as an adaptive myocardial response to chronically
reduced blood flow1 16 and as a consequence of repetitive or
cumulative stunning with or without an underlying reduc-
tion of baseline blood flow.4 17 The definition of the
pathophysiological background underlying the interaction
between stunning and hibernation is a debated, still unsolved
issue. This dichotomous interpretation essentially comes
from positron emission tomography studies where no2 4 18
or only slightly (20–30%)19 reduced blood flow was found in
hibernating myocardium with the use of different tracers.
Challenging these findings are studies carried out in our
laboratory showing that resting MBF is reduced in the
majority of myocardial segments in patients with isolated
LAD or circumflex coronary artery stenosis, regardless of the
presence or absence of asynergies.20 On the other hand, a true
reduction in resting MBF has been reported in patients with
chronic contractile dysfunction and tissue viability,21 in
patients with severe postischaemic dysfunction undergoing
heart transplantation,22 and in patients with stable angina,
isolated severe LAD stenosis, and mild contractile impair-
ment undergoing percutaneous transluminal coronary angio-
plasty.23
However, the acute setting addressed in this study allowed
us to assess simultaneously MBF and metabolism before and
after revascularisation and to show that immediate func-
tional recovery is associated with restoration of blood flow
and improvement in oxidative metabolism.
Functional recovery after revascularisation
Similar to initial observations in humans24 25 and to findings
in animal models,26 in our study we found recovery of
function soon after revascularisation. Conversely, subacute or
chronic recovery lasting from seven days up to several
months was reported in experimental27–29 as well as in
clinical30 31 studies. Several methodological aspects, including
characteristics of the studied population, experimental
design, and parameters used to assess viability and functional
recovery, have to be considered to explain these differences.
In particular, preoperative ejection fraction was just slightly
compromised in our patients; moreover, none of them had
acute myocardial infarction, and tissue viability was found in
71 of 78 (91%) LAD related dysfunctional segments by
imaging techniques. These characteristics identify a selected
model of hibernation with a high proportion of preserved
Table 3 Perioperative changes in myocardial blood flow, myocardial oxygen
consumption, and myocardial oxygen extraction
Preop Postop
Measurement 1 Measurement 2 Measurement 1 Measurement 2
Myocardial blood flow (ml/min)
Group 1 59 (6.7) 57 (6.9) 130 (14.0)** 128 (13.2)**
Group 2 111 (20.7) 114 (22.2) 106 (19.5) 104 (20.2)
p Value 0.004 0.003 0.358 0.352
Myocardial oxygen consumption (ml/min)
Group 1 5.9 (0.75) 5.6 (0.74) 9.7 (1.03)* 9.6 (0.91)*
Group 2 9.3 (1.45) 10.0 (2.17) 8.2 (1.67) 7.8 (1.80)
p Value 0.042 0.019 0.434 0.359
Myocardial oxygen extraction (%)
Group 1 57 (2.6) 56 (2.5) 62 (2.6) 61 (2.5)
Group 2 57 (3.6) 59 (4.6) 59 (2.9) 55 (4.4)
p Value 0.958 0.527 0.489 0.273
Data are mean (SEM).
*p,0.05 v preop 1 and preop 2; **p,0.001 v preop 1 and preop 2.
Figure 2 MBF determination in group 1 (circles) and group 2 (squares)
patients measured by GCV thermodilution technique. MBF post 1, first
postoperative determination; MBF post 2, second postoperative
determination; MBF pre 1, first preoperative determination; MBF pre 2,
second preoperative determination. *p,0.01 group 1 v group 2 before
revascularisation; **p,0.001 group 1 MBF before v after
revascularisation.
Figure 3 Myocardial extractions and transmyocardial fluxes of lactate
in (A) group 1 and (B) group 2 patients.
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myocytes32 33 where the degree of structural alterations is not
likely to prevent early functional recovery. Conversely,
delayed recovery of function is expected in the case of severe
morphological changes.5 31–33 In addition, evidence of oxida-
tive metabolism in segments with reduced blood flow is
consistent with the hypothesis of a true transmural decline in
flow in otherwise viable tissue rather than pseudoreduction
secondary to a mixture of scarred and normal tissue. On the
other hand, the presence of a transmurally extended patchy
component of scarred myocardium may interfere with
echocardiographic detection of contractile reserve.34
The duration of hibernation is also relevant in determining
the rate of functional recovery.27 Although we have no
definite information on this issue, LV dysfunction had been
detected at least one month before surgery by protocol in our
patients; moreover, onset of clinical symptoms lasted no
longer than one year. Finally, rapid recovery has been
suggested to reflect only transient improvement in function
due to afterload reduction or catecholamine stimulation.24 25
However, improved contractile function was still detectable
in our study population three months after revascularisation
when the haemodynamic changes induced by surgery were
no longer present.
The experimental setting of this study—that is, surgical
revascularisation in patients with sustained resting hypoper-
fusion—may have magnified the potential role of ischaemic
preconditioning in providing metabolic protection against
reperfusion injury after weaning from bypass and consequent
fast functional recovery. Therefore, the results of the present
study, in a group of patients with stable angina and a high
percentage of viable myocardium in dysfunctional areas,
support the hypothesis that resting MBF is greatly reduced in
this clinical setting. In fact, MBF was immediately restored
after revascularisation to values similar to those of patients
with normal function, whereas blood flow in the LAD related
territories of the latter group did not change after CABG
surgery.
MBF, oxygen util isation, and metabolism
The increase in MBF in viable myocardium soon after
revascularisation was paralleled by an increase in myocardial
oxygen consumption in the same territories, whereas there
was a very slight decrease in oxygen extraction. This finding
indicates that the increase in blood flow in the immediate
postoperative period supplies viable areas, allowing a
substantial increase of their preoperative aerobic metabolism.
The possibility that increases in MBF may be caused by a
hyperaemic response related to aortic cross clamping and
reperfusion can be ruled out because the pre-revascularisa-
tion and post-revascularisation oxygen extraction rates were
similar in both groups of patients and the repeated post-
revascularisation measurements of MBF, myocardial oxygen
consumption, and oxygen extraction were stable over time.
Our study also shows that the previously asynergic
segments recovered their contractility at the same time as
MBF and myocardial oxygen consumption increased, and
that this occurred under haemodynamic conditions that were
as similar as possible to those existing before surgery. The
confirmation of this immediate recovery of contractility by
follow up echocardiograms with no further improvement
suggests that, at least in our patient population, the
mechanisms underlying myocardial hibernation should be
ascribed to an adaptive metabolic condition rather than to
cell dedifferentiation4 or cell degeneration.5 In fact, these
mechanisms would require some time before restoration of
contractile function.
Our data suggest that hibernating territories maintain an
oxidative metabolic pattern before and after revascularisa-
tion; in fact, the glucose extraction ratio and uptake did not
Figure 4 Myocardial extractions and transmyocardial fluxes of glucose
in (A) group 1 and (B) group 2 patients.
Figure 5 Myocardial extractions and transmyocardial fluxes of free
fatty acids in (A) group 1 and (B) group 2 patients.
Table 4 Wall motion score index of LAD related
asynergic segments before and after surgical myocardial
revascularisation in group 1 patients
Echocardiographic method
Wall motion
score index
Preoperative transthoracic 2.8 (0.74)
Dobutamine stress 1.6 (1.01)*
Transoesophageal
Preoperative 2.6 (0.85)
Postoperative 1.5 (0.98)*
8 days’ follow up 1.6 (1.00)*
3 months’ follow up 1.6 (1.05)*
Data are mean (SEM).
*p,0.01 v preoperative transthoracic and preoperative
transoesophageal echocardiography.
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change in group 1 patients, whereas lactate and free fatty
acid uptakes increased significantly after revascularisation.
The increase in transmyocardial flow and consequent uptake
of both lactate and free fatty acids in group 1, together with
the lack of significant differences in utilisation of these
substrates in group 2, adds further strength to the hypothesis
that the immediate post-revascularisation increase in the
MBF of hibernating LAD areas is related to a prompt increase
in substrate oxidative utilisation.
Study limitations
The limitations of this study are that LAD related dysfunc-
tional territories may not have been homogeneous, with
normal, necrotic, and hibernating myocardium, and so our
evaluation of their blood flow and metabolism may reflect
different pathophysiological situations simultaneously
expressed in different LAD territories. However, we selected
patients with evidence of myocardial viability in most of the
asynergic segments at 201Tl-SPECT or dobutamine stress
echocardiography (. 90% of viable segments).
Another possible criticism is that we used the thermodilu-
tion technique to assess MBF in LAD territories, the accuracy
of which may be affected by heart motion or interventions
leading to large changes in heart size. However, the reflux of
right atrial blood into the coronary sinus (which may lead to
a spurious overestimate) can be ruled out on the basis of the
visually checked advanced positioning of the catheter tip in
the great cardiac vein.
Established techniques for measuring MBF are positron
emission tomography, the microsphere technique, and
intracoronary Doppler flow wires, which provide accurate
estimates of regional myocardial perfusion. However, in our
surgical experimental setting, the thermodilution modality
was the only suitable, safe, and reliable technique to calculate
resting MBF.
Lastly, the restricted range of our time points (30 minutes
after weaning from cardiopulmonary bypass) does not permit
the extension of these metabolic observations to the
subsequent postsurgical course.
Clinical implications
Our findings indicate that, when a high degree of viability in
asynergic myocardial areas can be documented preoperatively
by means of imaging techniques in patients with post-
ischaemic dysfunctional myocardium, revascularisation is
followed by a major increase in coronary blood flow and a
prompt recovery of contractility. The mechanism underlying
myocardial hibernation in this cohort of patients, with stable
angina pectoris and relatively recent onset of symptoms (less
than one year), can be ascribed to an adaptive mechanism to
preserve myocyte integrity in the setting of chronic coronary
flow restriction, which can be immediately improved by
effective revascularisation. We are aware that our conclusions
may apparently conflict with the emerging interpretation of
hibernating myocardium as a result of chronic stunning.
However, the peculiar characteristics of our experimental
setting—that is, functional assessment immediately after
blood flow restoration—provide a logical explanation for the
disagreement with part of the previous literature.
The use of non-invasive tests aimed at evaluating the lack
of pathological progression in hibernating myocardium may
identify patients in whom contractility most probably will
improve immediately after surgical revascularisation. This
insight appears to be helpful in clinical decision making and
management of those patients during surgical procedures.
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Delayed presentation of right ventricular bullet embolus
A
68 year old man presented in 1992
with syncope related to complete heart
block. A chest radiograph showed a
small calibre bullet that appeared to be
within the heart. A permanent pacemaker
was implanted.
He had fought on the Russian front during
the second world war, where he was
wounded on five occasions. On the last of
these he sustained a bullet wound to the left
side of his neck below the angle of the jaw
that healed, although the bullet was not
recovered.
Chest radiographs recorded in 2003 (59
years after he was wounded) show the
pacing electrode (*) and the bullet, which
echocardiography showed was within the
cavity of the right ventricle.
N Bett
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